SYNLOGIC, INC. Payments for (Proceeds from) Businesses and Interest in Affiliates
SYNLOGIC, INC. (SYBX) reported Payments for (Proceeds from) Businesses and Interest in Affiliates of -$40.43 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates · last filed 2019-03-12
- SYNLOGIC, INC. payments for (proceeds from) businesses and interest in affiliates for the quarter ending 2017-12-31 was $257.00K.
- SYNLOGIC, INC. payments for (proceeds from) businesses and interest in affiliates for fiscal 2017 was -$40.43M.
| Period end | Payments for (Proceeds from) Businesses and Interest in Affiliates 3 month | Payments for (Proceeds from) Businesses and Interest in Affiliates 9 month | Payments for (Proceeds from) Businesses and Interest in Affiliates 12 month |
|---|---|---|---|
| 2017-12-31 | $257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$40.43M 10-K · filed 2019-03-12 | |
| 2017-09-30 | -$40.69M 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |